id.DRIVE (former COVIDRIVE) study of brand-specific COVID-19 vaccine effectiveness against severe COVID-19 disease in Europe

First published 02/08/2021

Last updated 27/02/2025

EU PAS number:

EUPAS42328

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

COVIDRIVE_TND-VE_MasterProtocol_v3.1

English (3.85 MB - PDF)View document

Updated protocol

CVE_Master Protocol v6.0_21 Mar 2024.pdf

First published: 29/07/2024

English (883.8 KB - PDF)View document

Study results

Study results

COVIDRIVE_Pfizer interim.pdf

English (878.86 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents